Furthermore, other clinical and laboratory characteristics (including metabolic parameters and androgen parameters) according to the genotypes of TNF-alpha (−308 G/A), IL-6 (−174 G/C), and IL-1beta (−511 C/T) polymorphisms in the PCOS patients and the control group could not evaluated due to a lack of sufficient data. This evidence concerns the gene IL6 and polycystic ovary syndrome.